237 related articles for article (PubMed ID: 17363430)
1. Dendritic cell-based vaccine against coccidioides infection.
Awasthi S
Ann N Y Acad Sci; 2007 Sep; 1111():269-74. PubMed ID: 17363430
[TBL] [Abstract][Full Text] [Related]
2. Differences in expression of cell surface co-stimulatory molecules, Toll-like receptor genes and secretion of IL-12 by bone marrow-derived dendritic cells from susceptible and resistant mouse strains in response to Coccidioides posadasii.
Awasthi S; Magee DM
Cell Immunol; 2004; 231(1-2):49-55. PubMed ID: 15919369
[TBL] [Abstract][Full Text] [Related]
3. Immune response of vaccinated and non-vaccinated mice to Coccidioides posadasii infection.
Xue J; Hung CY; Yu JJ; Cole GT
Vaccine; 2005 May; 23(27):3535-44. PubMed ID: 15855012
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of the protective subcellular coccidioidal T27K vaccine.
Johnson SM; Kerekes KM; Lunetta JM; Pappagianis D
Ann N Y Acad Sci; 2007 Sep; 1111():275-89. PubMed ID: 17363436
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cells pulsed with Coccidioides immitis lysate induce antigen-specific naive T cell activation.
Richards JO; Ampel NM; Galgiani JN; Lake DF
J Infect Dis; 2001 Nov; 184(9):1220-4. PubMed ID: 11598850
[TBL] [Abstract][Full Text] [Related]
6. Molecular and cellular mechanisms of protective immunity to coccidioidomycosis.
Kirkland TN; Raz E; Datta SK
Vaccine; 2006 Jan; 24(4):495-500. PubMed ID: 16181709
[TBL] [Abstract][Full Text] [Related]
7. A recombinant aspartyl protease of Coccidioides posadasii induces protection against pulmonary coccidioidomycosis in mice.
Tarcha EJ; Basrur V; Hung CY; Gardner MJ; Cole GT
Infect Immun; 2006 Jan; 74(1):516-27. PubMed ID: 16369008
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of antigen 2/proline-rich antigen cDNA-transfected dendritic cells in immunization of mice against Coccidioides posadasii.
Awasthi S; Awasthi V; Magee DM; Coalson JJ
J Immunol; 2005 Sep; 175(6):3900-6. PubMed ID: 16148136
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis.
Herr RA; Hung CY; Cole GT
Infect Immun; 2007 Dec; 75(12):5777-87. PubMed ID: 17875631
[TBL] [Abstract][Full Text] [Related]
10. Rational Design of T Lymphocyte Epitope-Based Vaccines Against Coccidioides Infection.
Hurtgen BJ; Hung CY
Methods Mol Biol; 2017; 1625():45-64. PubMed ID: 28584982
[TBL] [Abstract][Full Text] [Related]
11. A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB/c mice against coccidioidomycosis.
Xue J; Chen X; Selby D; Hung CY; Yu JJ; Cole GT
Infect Immun; 2009 Aug; 77(8):3196-208. PubMed ID: 19487479
[TBL] [Abstract][Full Text] [Related]
12. In vivo trafficking and immunostimulatory potential of an intranasally-administered primary dendritic cell-based vaccine.
Vilekar P; Awasthi V; Lagisetty P; King C; Shankar N; Awasthi S
BMC Immunol; 2010 Dec; 11():60. PubMed ID: 21143974
[TBL] [Abstract][Full Text] [Related]
13. Preclinical identification of vaccine induced protective correlates in human leukocyte antigen expressing transgenic mice infected with Coccidioides posadasii.
Hurtgen BJ; Castro-Lopez N; Jiménez-Alzate MDP; Cole GT; Hung CY
Vaccine; 2016 Oct; 34(44):5336-5343. PubMed ID: 27622300
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of TLR4-defective C3H/HeJ mice to Coccidioides posadasii infection.
Awasthi S
Med Mycol; 2010 May; 48(3):470-5. PubMed ID: 20370361
[TBL] [Abstract][Full Text] [Related]
15. The Rise of
Van Dyke MCC; Thompson GR; Galgiani JN; Barker BM
Front Immunol; 2019; 10():2188. PubMed ID: 31572393
[TBL] [Abstract][Full Text] [Related]
16. Unique functions of splenic CD8alpha+ dendritic cells during infection with intracellular pathogens.
Neuenhahn M; Busch DH
Immunol Lett; 2007 Dec; 114(2):66-72. PubMed ID: 17964665
[TBL] [Abstract][Full Text] [Related]
17. Protein expression profiling of Coccidioides posadasii by two-dimensional differential in-gel electrophoresis and evaluation of a newly recognized peroxisomal matrix protein as a recombinant vaccine candidate.
Orsborn KI; Shubitz LF; Peng T; Kellner EM; Orbach MJ; Haynes PA; Galgiani JN
Infect Immun; 2006 Mar; 74(3):1865-72. PubMed ID: 16495561
[TBL] [Abstract][Full Text] [Related]
18. An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection.
Hung CY; Hurtgen BJ; Bellecourt M; Sanderson SD; Morgan EL; Cole GT
Vaccine; 2012 Jun; 30(31):4681-90. PubMed ID: 22575167
[TBL] [Abstract][Full Text] [Related]
19. Improved protection of mice against lethal respiratory infection with Coccidioides posadasii using two recombinant antigens expressed as a single protein.
Shubitz LF; Yu JJ; Hung CY; Kirkland TN; Peng T; Perrill R; Simons J; Xue J; Herr RA; Cole GT; Galgiani JN
Vaccine; 2006 Jul; 24(31-32):5904-11. PubMed ID: 16759762
[TBL] [Abstract][Full Text] [Related]
20. Molecular identification of coccidioides isolates from Mexican patients.
Castañón-Olivares LR; Güereña-Elizalde D; González-Martínez MR; Licea-Navarro AF; González-González GM; Aroch-Calderón A
Ann N Y Acad Sci; 2007 Sep; 1111():326-35. PubMed ID: 17344538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
